Xu Cong Claire's Form 4 filing
NovaBridge Biosciences (NBP) · filed Sep 1, 2026
- Accession no.
- 0002114309-26-000007
- Filed
- Sep 1, 2026, 6:00 PM ET
- Trade date
- Aug 30-31, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.59K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Xu Cong ClaireCIK 0002114309 | Officer (EVP, Clinical Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2026 | Ordinary Shares | MOption exerciseAcquired | +9,382 | – | – | 307,483 | Direct | |
| Aug 31, 2026 | Ordinary Shares | SSaleDisposed | −3,282 | $0.79 | −$2,592.78 | 304,201 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2026 | Ordinary Shares | MOption exerciseDisposed | −4,079 | $0.00 | $0 | 28,558 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.